thus , the tumor cells in certain patients with ctcl may derive from a monoclonal proliferation of a t-cell subset capable of producing humoral bone-resorbing factor ( s ) similar to those demonstrated in cultures of mitogen- and antigen-activated normal lymphocytes .
C0007634
the
C1155046
proliferation